Back
Corporate News
Sun Pharma Advanced Research to review financial results at August 10 board meeting
03-Aug-2026, 04:26
Sun Pharma Advanced Research Company Ltd will hold a board meeting on August 10, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing with the National Stock Exchange of India Ltd and BSE Limited. The trading window for company shares has been closed for directors, key managerial personnel, designated employees, and connected persons since July 1, 2026, and will remain closed until 48 hours after the financial results are declared and submitted to the stock exchanges.
Sun Pharma Advanced Research Company Ltd will hold a board meeting on August 10, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing with the National Stock Exchange of India Ltd and BSE Limited. The trading window for company shares has been closed for directors, key managerial personnel, designated employees, and connected persons since July 1, 2026, and will remain closed until 48 hours after the financial results are declared and submitted to the stock exchanges.